India to Nicaragua: Cetuximab Export Trade Route

The India to Nicaragua Cetuximab corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $129.6K USD. The route is dominated by CAPLIN POINT LABORATORIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's cetuximab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $129.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with cetuximab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 28.4%, placing it at rank #18 among India's top cetuximab export destinations globally.

On the import side, key buyers of Indian cetuximab in Nicaragua include NEOETHICALS, S.A,. NEOETHICALS, S.A, is the single largest importer with 1 shipments valued at $129.6K USD.

India's cetuximab exports to Nicaragua are driven primarily by a handful of large-scale manufacturers. CAPLIN POINT LABORATORIES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Nicaragua benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CAPLIN POINT LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $129.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, NEOETHICALS, S.A, is the largest importer with 1 shipments worth $129.6K USD — representing 100% of all cetuximab imports from India on this route.